33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.17%
Revenue growth above 1.5x MDB's 9.41%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.03%
Gross profit growth above 1.5x MDB's 8.59%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
19.09%
Positive EBIT growth while MDB is negative. John Neff might see a substantial edge in operational management.
19.09%
Positive operating income growth while MDB is negative. John Neff might view this as a competitive edge in operations.
18.38%
Positive net income growth while MDB is negative. John Neff might see a big relative performance advantage.
23.53%
Positive EPS growth while MDB is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.53%
Positive diluted EPS growth while MDB is negative. John Neff might view this as a strong relative advantage in controlling dilution.
5.82%
Share count expansion well above MDB's 3.37%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.82%
Diluted share count expanding well above MDB's 3.37%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-20.97%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-17.32%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.16%
R&D growth drastically higher vs. MDB's 11.81%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.66%
SG&A declining or stable vs. MDB's 11.60%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.